Immunofluorescence Assay Market – Top 3 Players and there Market Growth

09.12.2019 - 12:39 | 1777834


Artikel von marketsandmarkets

The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market.

The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the immunofluorescence assay market.

Market Size
The global Immunofluorescence Assay market size is projected to reach USD 2.01 Billion by 2023 from an estimated USD 1.51 Billion in 2018, at a CAGR of 5.8%.

Thermo Fisher (US), Inova Diagnostics (US), and PerkinElmer (US), Merck Millipore (US), Bio-Rad (US), Abcam (UK), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.

For More Details, Download a PDF Brochure:-
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571

“Thermo Fisher (US) held the leading position in the global immunofluorescence assay market in 2017”
The company provides antibodies, reagents, and kits used in immunofluorescence assays through its Life Science Solutions segment. It has operations in more than 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. The company focused on both organic as well as inorganic growth strategies to maintain its leading position in the global immunofluorescence assay market. For instance, in 2016, the company launched Evos FL Auto 2 Imaging System. In the same year, the company also signed an agreement with EUROIMMUN (Germany). Through this agreement, it would be offering indirect immunofluorescence (IFA) test kits that can differentiate between Zika, dengue, and chikungunya viruses manufactured by EUROIMMUN AG in the US market.

“Inova Diagnostics is among the leading players in the global immunofluorescence assay market”
The company manufactures in-vitro diagnostics (IVD) systems and reagents for clinical laboratories and hospitals. It offers its immunofluorescence assay products under the brand name NOVA. The company strengthened its market place by adopting product launches as its growth strategy. For instance, in 2017, the company launched QUANTA-Lyser 3000. In the same year, the company again launched two NOVA Lite reagents. This strategy helped the company to enhance its product portfolio in the immunofluorescence assay market.



We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-
https://www.marketsandmarkets.com/requestsampleNew.asp?id=255585571

Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Leseranfragen:

PresseKontakt / Agentur:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Anmerkungen:

1777834

Kontakt-Informationen:
Vor- / Nachname: marketsandmarkets

Ansprechpartner: Mr. Shelly Singh
Stadt: northbrook
Telefon: 8886006441

Keywords (optional):
immunofluorescence-assay-market, immunofluorescence-assay, immunofluorescence,

Dieser Artikel wurde bisher 66 mal aufgerufen.

Verlinkung-Tipps:



Direkter Link zu diesem Artikel:




Diese Pressemeldung bookmarken bei...


Tausendreporter BlinkList del.icio.us Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.


Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht internet-intelligenz.de


[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]


Alle Artikel von marketsandmarkets RSS Feed

Hillrom und der UK Sepsis Trust kündigen exklusive Partnerschaft in 2020 zur Sepsis-Aufklärung an
Cognate BioServices beendet Serie-B-Finanzierungsrunde und schließt Übernahme von Cobra Biologics ab
Hitzler Ingenieure arbeitet erneut mit derösterreichischen Bundesimmobiliengesellschaft zusammen
Erstzulassung für Tigilanol Tiglat von QBiotics: Europäische Arzneimittelagentur EMA erteilt Zulassung für Stelfonta®
FDA bestätigt das Phagenyx® System, welches mittels Behandlung von neurogener Dysphagie die sichere Entfernung der Beatmungskanüle beschleunigt, als Breaktrough Device





Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by TopBlogs.de